Previous studies indicated that most patients with E. coli-asparaginase allergy also have a neutralizing antibody to the enzyme, resulting in sub-therapeutic systemic asparaginase activity even if allergic symptoms are prevented by the use of antihistamines and other premedications34, 35, 36, 37, 38. This evidence concerns the gene ASPG and allergic disease.